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Analisis Ekstrak Air Ikan Haruan (Channa striatus) dan Kajian Haruan 
Aerosol terhadap Penyembuhan Luka 
ABSTRAK 
Ciri mempercepat penyembuhan luka ekstrak air ikan haruan telah dikaji. Kajian  in 
vitro dan in vivo mengunakan titisan sel dan model haiwan telah dipilih untuk 
mencerminkan kesan penyembuhan. Analisa ekstrak air ikan haruan telah dijalankan 
untuk menentukan kandungan asid amino dan asid lemak. Penentuan asid amino 
dalam ekstrak air ikan haruan telah dijalankan menggunakan kaedah hidrolisis asid, 
diikuti oleh derivatisasi AQC pra-turus dan dianalisis menggunakan kromatografi 
cecair prestasi tinggi yang dilengkapi dengan pengesan pendarfluor, sementara 
penentuan asid lemak dilakukan menggunakan kaedah metilasi asid dengan 
kromatografi gas yang dilengkapi dengan pengesan pengionan nyalaan . Pengesahan 
kaedah juga telah dibangunkan untuk memastikan data yang diperolehi boleh 
dipercayai dan sah bagi kedua-dua analisis asid amino dan asid lemak. Keputusan 
parameter pengesahan menunjukkan bahawa semua data yang diperolehi berada 
dalam julat mengikut nilai yang boleh diterima oleh garis panduan ICH. Penentuan 
asid amino menunjukkan bahawa ekstrak air ikan haruan mengandungi sekurang-
kurangnya 16 asid amino yang mana glisin dan asid glutamik (masing-masing 
17,51% dan 14,32% daripada jumlah asid amino)  adalah asid amino utama dalam 
ekstrak. Sebaliknya, tirosin diikuti oleh histidin adalah asid amino yang paling 
sedikit.  Analisis asid lemak menunjukkan bahawa terdapat sekurang-kurangnya 18 
asid lemak yang dikenal pasti dalam ekstrak air ikan haruan yang dikategorikan 
sebagai asid lemak tepu, asid lemak mono tak tepu, dan asid lemak poli tak 
tepu. Asid lemak yang paling banyak di dalam ekstrak air ikan haruan asid adalah 
xix 
 
asid palmitik diikuti oleh asid palmitoleik ( masing-masing 39,12% dan 11,28%  
daripada jumlah asid lemak).  Sementara itu, asid laurik dan asid erusik merupakan 
asid lemak yang paling sedikit.  Kajian in vitro telah dijalankan menggunakan 
kaedah penyembuhan luka gores untuk menilai kesan ekstrak air ikan haruan dalam 
penghijrahan sel-sel yang cedera. Hasilnya menunjukkan bahawa ekstrak air ikan 
haruan menggalakkan penutupan luka sel epidermis tikus dengan kadar 5% 
berbanding dengan kawalan. Kadar ini kemudiannya dipilih untuk diformulasikan 
dalam bentuk dos aerosol dan digunakan untuk kajian in vivo. Dalam kajian ini ujian 
kereaktifan biologi dan kajian keberkesanan penyembuhan luka dijalankan.  Ujian 
kereaktifan biologi telah dijalankan ke atas model haiwan mencakupi tiga jenis 
eksperimen yaitu ujian Kerengsaan Kulit Rendah, ujian Intracutaneous, dan ujian 
Suntikan Sistemik. Hasil kajian menunjukkan bahawa aerosol Haruan tidak memberi 
sebarang tindak balas yang signifikan kepada semua ujian. Penyiasatan kesan aerosol 
Haruan sebagai penutup luka dalam proses pemulihan dilakukan menggunakan tikus 
Sprague-Dawley di mana luka hirisan dan luka bakar telah dibuat ke atas belakang 
haiwan-haiwan. Aerosol Haruan diuji dan dibandingkan dengan formula kosong 
sebagai kawalan. Ujian kekuatan tegangan, pengecutan luka dan parameter 
histopathologi telah dipilih sebagai hasil untuk mengukur kejayaan 
penyembuhan. Hasil kajian menunjukkan bahawa aerosol Haruan memberi 
penguncupan luka yang signifikan pada minggu pertama penyembuhan dan 
meningkatkan proses pemulihan yang disokong oleh data histopathologi. Dari semua 
keputusan, dapat disimpulkan bahawa aerosol haruan dengan ekstrak air ikan haruan 
sebagai bahan aktif mempunyai potensi yang besar untuk menggalakkan proses 
penyembuhan luka dan mempercepatkan masa penyembuhan dengan prosedur 
terapeutik yang selamat dan mudah. 
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Analysis of Haruan (Channa striatus) Water Extract and the Study of Haruan 
Aerosol on Wound Healing  
ABSTRACT 
The enhancement of wound healing properties of haruan water extract has been 
studied. The in vitro and in vivo studies using cell line and animal model were 
carried out to evaluate the effectiveness of the extract. Analytical study of haruan 
water extract was conducted to determine the amino acid and fatty acid contents.  
The determination of the amino acid in haruan water extract was carried out using 
acid hydrolysis method, followed by AQC pre-column derivatization and analysed 
using high performance liquid chromatography equipped with fluorescence detector, 
while the fatty acid determination was performed using acid methylation method 
with gas chromatography equipped with flame ionization detector. A method 
validation was also established to ensure the data obtained reliable and valid for both 
amino acid and fatty acid analysis. The results of validation parameters showed that 
all the data obtained were in the range of acceptable value accordance to ICH 
guideline. The results showed that haruan water extract containing at least 16 amino 
acids of which glycine and glutamic acid were the major component of the amino 
acids (17.51% and 14.32% respectively of total amino acid) in the extract. While, 
tyrosine followed by histidine was the least amino acids. The fatty acid analysis 
showed that there were at least 18 fatty acids identified in haruan water extract which 
were categorized as saturated fatty acid, monounsaturated fatty acid, and 
polyunsaturated fatty acid. The most abundant fatty acid in haruan water extract is 
palmitic acid followed by palmitoleic acid (39.12% and 11.28% respectively of total 
fatty acid).   While lauric acid and erucic acid is the least fatty acid found in the 
xxi 
 
extract.  The in vitro study was carried out using wound healing scratch assay to 
evaluate the effect of haruan water extract in the migration of wounded cells.  It 
showed that haruan water extract promoted the wound closure of mouse epidermal 
cells at the concentration of 5% as compared to its control. This concentration was 
then selected for the formulation of aerosol dosage form and was used in the in vivo 
study. In this study a biological reactivity test and wound healing efficacy study were 
carried out. Biological reactivity test was carried out on animal models encompass 
three types of experiments which are the Primary Skin Irritation test, the 
Intracutaneous test, and the Systemic Injection test. The results showed that Haruan 
aerosol gave no significant response to all the tests. The investigation of the effect of 
Haruan aerosol as wound dressing in the healing process was performed in Sprague-
Dawley rats where full-thickness incision wound and burn wound were made on the 
back of the animals. Haruan spray was tested and compared with blank formula as 
control. Tensile strength test, wound contraction and histopathology parameters were 
selected as the outcomes to measure the success of the healing. The results showed 
that haruan aerosol gave a highly significant wound contraction in the first week of 
healing and improved the healing process which was supported by the histopathology 
data. From all of the results,  it can be concluded that Haruan aerosol with haruan 
water extract as active ingredient has a great potential to promote wound healing 
process and accelerate the healing time with safe and simple therapeutic procedure.  
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CHAPTER 1 
    INTRODUCTION 
                                                                                                                                                                                                                                               
 
1.1. HARUAN FISH 
Haruan fish is a well known fresh water fish in Malaysia. It is a species of 
snakehead that scientifically known as Channa striatus. It is also known as stripped 
snakehead, common snakehead, and snakehead murrel. This fish belongs to the 
family of Channidae and it is mostly distributed in many tropical countries such as 
Malaysia, Indonesia, Singapore, Thailand, Indochina and India (Lee and Ng, 1994, 
Lowe-McConnell, 1987, Alfred, 1966, Qasim and Bhatt, 1966, Fowler, 1938, 
Maxwell, 1921). 
  Traditionally, haruan fish is used by rural folks especially mothers after 
giving birth and people who have undergone surgery. They believe that by eating this 
fish, they will gain strength and promote wound healing. Haruan is also encouraged 
to be taken by Chinese women after giving birth as food supplement during 
confinement (Koon and Karim, 2005). 
In the past 15 years, many studies have been conducted in relation to haruan 
fish. The results showed that haruan fish has many other advantages not only in 
wound healing. Several findings on studies of haruan fish are tabulated in Table 1.1.  
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 Table 1.1: Role of haruan in several studies 
 
1.2. SKIN  
Skin is the largest and most complex organ that covers the whole body surface of a 
human body (15% of total adult body weight). It has multiple vital functions i.e. 
protection against external physical, chemical, and biological aggressions; 
maintenance of its homeostatis; storage of nutrients; excretion of substances; the 
synthesis of vitamin; and sensing (Martini, 2007, Kanitakis, 2002, Walters and 
Roberts, 2002). It consists of 3 layers including from top to bottom namely 
epidermis, dermis and hypodermis which organise several tissues of various cells 
(epithelial, connective, muscular and nervous) (Kanitakis, 2002). 
Pharmacology 
Activity 
Part that used Result Reference 
Wound healing Fish extract 
 
Mucus and Roe 
Positive 
 
Positive 
Baie and Sheikh 
(2000a, 2000b) 
 
Mat Jais et al.(1998) 
Antinociceptive Fillet extract and mucus 
extract 
 
Aqueous supernatant 
extract 
Positive Mat Jais et al. (1997), 
Dambisya et al. 
(1999) 
Zakaria et al. (2007) 
Anti-inflammatory 
for osteoarthritis 
Fillet extract Positive Michelle et al. (2004) 
Lowering blood 
glucose and 
cholesterol level 
Fillet extract Negative Mat Jais et al. (2002) 
Mild antibacterial 
and antifungal 
Fish extract Positive Mat Jais (2007) 
Platelet aggregation 
and blood clotting 
Fish extract Positive 
Unpublished work by 
Mat Jais 
  
3 
 
EPIDERMIS 
DERMIS 
HYPODERMIS 
 
Figure 1.1: Anatomic structure of normal skin (adopted from www.google.com) 
 
1.2.1. Epidermis 
Epidermis is made up of several cells types, the majority (90 to 95%) is keratinocyte 
cells, the rest (5 to 10%) are Langerhans cells, melanocytes and Merkel cells 
(Kanitakis, 2002). Epidermis has five layers or zones that are recognizable that is 
stratum corneum (nonviable epidermis), stratum lucidum, stratum granulosum, and 
stratum germinativum which is divided into stratum spinosum and stratum basale 
(cylindricum) (Di-Fiore, 1967). The average thickness of epidermis is approximately 
100 µm (Kanitakis, 2002). In the epidermis layers, stratum corneum has an important 
role. It is the very outside layer of the skin. The thickness of stratum corneum is 
approximately 10 to 20 µm. The functions of the epidermis are based on the layers 
Stratum corneum 
Stratum lucidum 
Stratum granulosum 
    Stratum spinosum 
Stratum basale 
Stratum 
germinativum  
 
Papillary region 
Reticular region 
Adipose tissue 
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that organise it. Stratum corneum as the nonviable epidermis is a barrier to a physical 
interaction as well as acts to prevent the loss of the internal body components, 
particularly water, to the external environment. The functions of viable epidermis are 
to form and maintain the generation of stratum corneum, metabolism of substrates, 
including foreign substances, synthesis of melanin for skin pigmentation and as 
protection against the sun (Walters and Roberts, 2002). 
 
1.2.2. Dermis 
The second layer is the dermis, a supportive, compressible and elastic connective 
tissue which protects the epidermis (Kanitakis, 2002). The main cells present in the 
dermis are fibroblast cells which make up 70% of dermis as a collagenous fibre 
tissue for stretch and for strength, as well as abundance in blood vessels and 
specialized nerve endings (Sherwood, 2008, Kanitakis, 2002). The thickness of 
dermis is about 0.1 to 0.5 cm, varying depending on the anatomic location. The 
functions of dermis are to provide the nutritive, immune, support system for the 
epidermis, and play a role in the temperature, pressure, and pain regulation. In the 
dermis, there are extensive vascular network which provide the skin with nutrition, 
repair wounds and immune response. The lymphatic system regulates pressure, 
mobilises defence mechanism and waste removal. There are also nerve fibres that 
give the skin with sensory of pressure, pain and temperature (Walters and Roberts, 
2002). 
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1.2.3. Subcutaneous layer (hypodermis) 
Subcutaneous layer is the deepest part of the skin consisting of fat cells (adipocytes), 
fibroblast and macrophages. The functions of subcutaneous tissue are heat insulator, 
shock absorber, energy storage, anchoring the skin to the underlying muscle; 
carrying the vascular and neural system to the skin (Kanitakis, 2002; Walters and 
Roberts, 2002). 
 
1.2.4. Dermal – Epidermal Junction (DEJ) 
This junction is a complex basement membrane synthesised by the basal epithelial 
cells and dermal fibroblasts. This junction is important for supporting the epidermis 
to the dermis and regulating the exchange of metabolic products between the two 
layers. In wound healing process, this junction plays an important role in serving as a 
support for the migration of epithelial cells (Kanitakis, 2002). 
 
1.3. WOUND DEFINITION 
There are many definitions for wound. Enoch and Leaper (2007) defined wound as a 
break in the epithelial integrity of the skin and may be accompanied by disruption of 
the structure and function of the underlying normal tissue. Winkler and Makowski 
(2005) defined wound as any physical break in tissue continuity. Cockbill (2002) 
defined wound as any process which leads to the disruption of the normal 
architecture of a tissue. Wound Healing Society defined wound as a disruption of 
normal anatomic structure and function (Lazarus et al., 1994). Stephen Thomas 
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(1990) defined wound as a defect or break in the skin that results from physical, 
mechanical or thermal damage, or that develops as a result of the presence of an 
underlying medical or physiological disorder. 
As a conclusion, it can be summarised that a wound is a disruption or a break in the 
skin or tissue that affects the normal anatomic structure and function resulting from 
physical, mechanical or thermal damage. 
 
 1.4. TYPE OF SKIN WOUND 
According to the number of skin layers affected, wound can be classified into 3 parts 
(Cockbill, 2002): 
a. Superficial wound 
The damage caused is limited to the epithelial tissue alone or epidermis layer 
and the healing will go rapidly by regeneration of epithelial cells. 
b. Partial thickness wound 
The disruption is involved in the deeper dermal layer and included vessel 
damage. 
c. Full thickness wound 
This type of wound affects the subcutaneous layer and beyond. It usually 
takes longer time to heal. 
The common classes of wound according to Thomas (1990) are: 
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1.4.1. Mechanical injuries 
The types of wound that included in this class are: 
a. Abrasions (grazes) 
The wound is generally caused by friction between skin and second 
harder or rougher surface. 
b. Lacerations (tears) 
It is more severe than abrasions which involve the underlying tissues. 
c. Penetrating wound 
This type of wound is generally caused by any sharp or pointed object 
which penetrated the skin beneath such as caused by knives, bullets or 
other sharp objects. 
d. Bites 
It is caused by animals or humans. 
e. Surgical wound 
This type represents mechanical injury caused by surgery process. 
1.4.2. Burns and chemical injuries  
There are several types of burn injury through aetiology: thermal, chemical, 
electrical, and radiation. The most common injury is caused by thermal. The 
classification of burn wound type depends on how deep the skin layer is affected. 
They are usually termed as degree of the burn. 
  
8 
 
a. First degree: burns involve only the epidermis and superficial layers of 
the dermis. 
b. Second degree: most surface of the epithelium is destroyed with much of 
the deeper dermal layer affected.  
c. Third degree: all elements of the skin are destroyed. 
 
                                                               
Figure 1.2: Depth of tissue in burn wound injuries (adopted from Myers, 2008) 
 
1.5. WOUND HEALING  
Wound healing is a complex, dynamic, interactive and collaborative process 
involving cellular and biochemical processes like variety of soluble mediators, cells, 
extracellular matrix that relate to achieve a common goal of tissue regeneration in the 
restoration of anatomic and function of injured part (Boateng et al., 2008, Kumar et 
al., 2004, Steed, 2003, Singer et al., 2000, Lazarus et al., 1994).  
Full 
thickness 
 
superficial 
Superficial 
Partial thickness Deep partial 
thickness 
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There are several types of wound healing based on the intentions: 
 Primary healing (healing by first intention) 
Most of clean surgical incision or laceration wounds with minimal bacterial 
contamination and no significant tissue lost are healed by primary closure 
(Enoch and Leaper, 2007, Halloran and Slavin, 2002, Thomas, 1990). The 
edges of the wound are directly closed with sutures, tissue glue, tapes or 
mechanical devices within 12-24 hours (Enoch and Leaper, 2007). 
This primary healing is initiated by the movement of epithelial cells from the 
edges of the wound to move closer to each other (Cockbill, 2002). The 
epithelial cells are proliferated in dermal – epidermal junction (Halloran and 
Slavin, 2002). 
 Delayed primary healing 
This type of healing is similar to the primary healing. The only difference is 
that there is contamination of bacteria or the wound closed a few days after 
the injury which delayed the healing process for several days (Enoch and 
Leaper, 2007). 
 Secondary healing (healing by second intention) 
This healing type is also known as open granulation (Thomas, 1990). The 
tissue damages are often greater (Halloran and Slavin, 2002). The skin wound 
loss of soft tissue extensively as a result of trauma, surgery or severe burn 
(Enoch and Leaper, 2007, Cockbill, 2002, Thomas, 1990). The healing begins 
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with the creation of granulation tissue at the base of the wound (Cockbill, 
2002). 
 Healing of superficial wounds 
The injury involves only the epithelium and the superficial of dermis such as 
superficial burn, split-thickness donor graft sites, and abrasions. Thus the 
healing occurs only by epithelialisation (Enoch and Leaper, 2007).  
 
 
Figure 1.3: Types of wound healing intention (adopted from Strodtbeck, 2001) 
Wound healing process starts immediately after injury has occurred (Cockbill, 2002). 
The healing process is an overlapping phase which is also a continual process that 
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conceptually moving toward to the next phases (Lorenz and Longaker, 2008). Some 
researchers divide the healing process into three phases (Kondo and Ishida, 2010, 
Lorenz and Longaker, 2008, Grazul-Bilska et al., 2003, Steed, 2003, Cockbill, 2002), 
four phases (Guo and DiPietro, 2010, Menke et al., 2008, Eccleston, 2007, Enoch 
and Leaper, 2007, Oberyszyn, 2007, Gosain and DiPietro, 2004, Williamson and 
Harding, 2004), and five phases (Boateng et al., 2008, Monaco and Lawrence, 2003, 
Prathiba and Gupta, 2000). 
 
1.5.1. Haemostasis phase 
Usually immediately after skin injury, bleeding will occur to flush out bacteria and 
antigen from the wound (Boateng et al., 2008). This bleeding process will be stopped 
by haemostasis. When a wound appears, blood quickly escapes from the blood 
vessels. Thus, vascular response occurs immediately after the skin gets injured. The 
first response is vasoconstriction of blood vessel to reduce the flow of blood 
(Monaco and Lawrence, 2003, Irvin, 1985). Vasoconstriction occurred by the 
liberation of adrenaline to the peripheral circulation when the dermis is penetrated 
(Monaco and Lawrence, 2003). 
Bleeding is stopped with the clot formation produced by platelets aggregation. 
Platelets aggregation is activated by contacting with thrombin and mature collagen 
(Thomas, 1990). During the aggregation and adhesion, platelets release some content 
of alpha granules (contain variety of immunomodulatory and proteinaceous factor 
include albumin, fibrinogen, fibronectin, IgG, coagulation factors V and VIII, and 
growth factors), dense bodies (include calcium, serotonin, ADP and ATP), and 
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lysosomal enzymes that draw more platelets to the injured area (Monaco and 
Lawrence, 2003).  
At the same time, thromboplastin liberated from the wounded cells will cleave 
fibrinogen to fibrin monomers to produce fibrin network. Platelets aggregation and 
fibrin network together form a strong clot that gives strength and support to the 
injured wound (Keast and Orsted, 1998, Thomas, 1990). 
 
1.5.2. Inflammatory phase 
The inflammatory phase occurs about the same time with haemostasis, thus in 
several references, haemostasis and inflammation both appear in the first phase 
(Boateng et al., 2008, Lorenz and Longaker, 2008, Cockbill, 2002, Singer and Clark, 
1999, Witte and Barbul, 1997). Sometimes starts within a few minutes after injury 
and lasts for 3 to 4 days (Boateng et al., 2008, Lorenz and Longaker, 2008, Keast and 
Orsted, 1998). 
The symptoms of inflammation process include redness, swelling, heat and pain 
occurring at the wound site (Diegelmann and Evans, 2004, Monaco and Lawrence, 
2003, Cockbill, 2002, Keast and Orsted, 1998). These signs start to occur when 
vasodilatation appeared and gaps occurred between the vascular endothelial cells, 
which permit the plasma to fill up the site of injury via diapedesis and causing the 
area around the wound to become swollen (known as edema) (Cockbill, 2002). The 
increase in surface area of the dilated vessel results in greater visualibility of the 
capillaries making the injured wound reddish in colour, while the heat transfer to the 
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surrounding tissues making the wound area warm to touch. The agents that are 
responsible for the vasodilatation and vascular permeability action are leukotriene, 
serotonin, bradykinin, prostaglandin and in particular histamine (Lorenz and 
Longaker, 2008, Grazul-Bilska et al., 2003, Monaco and Lawrence, 2003, Thomas, 
1990, Hunt, 1988, Peacock, 1984). 
The goal of the inflammatory phase is to clean up all the debris that occurred at the 
wound area. Neutrophils start to appear in the wound site within hours followed by 
macrophages (Thomas, 1990). Both of these agents have roles in debris removal and 
bacteria ingestion through phagocytosis and intracellular killing (Martin et al., 1992). 
At the late inflammatory phase (2 to 3 days), the macrophages dominate the wound 
site replacing the neutrophils and release cytokines (include growth factors) also 
immunomodulatory factors that initiate the next stage of healing process (Lorenz and 
Longaker, 2008, Monaco and Lawrence, 2003). 
 
1.5.3. Proliferation phase 
When the inflammation process is near to the end, the proliferation phase begins on 
day 3 and lasts until 2-3 weeks (approximately 21 days) after injury (Enoch and 
Leaper, 2007, Keast and Orsted, 1998, Hanna and Giacopelli, 1997), depending on 
the site and size of the wound (Peacock, 1984). This phase is characterized by three 
parts: migration of fibroblast cells, deposition of extracellular matrix (ECM) and 
formation of granulation tissue. Epithelialisation process will appear at the end as a 
representative of final stage of the proliferation phase (Enoch and Leaper, 2007). 
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a. Fibroblast Migration 
Fibroblasts are the key factors in the proliferation phase. Fibroblasts migrate to the 
wound site around 2- 4 days after injury (Enoch and Leaper, 2007). Proliferation and 
migration of fibroblast cells are induced by growth factors and cytokines (Lorenz and 
Longaker, 2008, Diegelmann and Evans, 2004, Kumar et al., 2004, Grazul-Bilska et 
al., 2003, Monaco and Lawrence, 2003, Singer and Clark, 1999, Walsh, 1998, 
Lawrence and Diegelmann, 1994). Fibroblasts move into the wound using the fibrin 
and fibronectin matrix. Once fibroblast cells are divided and proliferated, they start 
the synthesis and secretion of extracellular matrix components (Lorenz and 
Longaker, 2008). 
b. Extracellular Matrix (ECM) Deposition  
The deposition of ECM in the wound area is to provide a substratum for cell 
adhesion and also for the regulation of growth, movement, and differentiation of the 
cells within it (Enoch and Leaper, 2007). The major cells related to ECM are the 
fibroblasts which are responsible for the production of ECM components (Lorenz 
and Longaker, 2008, Cockbill, 2002). The components in ECM are described as 
follow: 
1. Fibrous structural proteins 
The structural proteins in ECM are collagen and elastin (Enoch and Leaper, 2007, 
Cockbill, 2002). Collagen and elastin are synthesised by the fibroblast (Boateng et 
al., 2008, Enoch and Leaper, 2007, Cockbill, 2002, Hanna and Giacoppelli, 1997). 
Collagen molecules also known as tropocollagen is consisted of three polypeptides 
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α- chain woven into a rope-like triple helix. Each α-chain has a repetitive sequence of 
amino acids where every third amino acid is glycine (Enoch and Leaper, 2007; 
Halloran and Slavin, 2002). Collagens are differentiated to 11 types based on the 
difference of α-chain (Halloran and Slavin, 2002). Only collagen I-III gives the 
fibrillar form (Enoch and Leaper, 2007, Halloran and Slavin, 2002, Brinckmann et 
al., 1994) and creates most of the connective tissue in the healing wounds. The other 
collagen types (e.g. type IV) are non-fibrillar and contribute as the component of 
basement membrane (Enoch and Leaper, 2007, Halloran and Slavin, 2002). Elastin is 
a highly insoluble protein that gives skin the elasticity (Monaco and Lawrence, 2003, 
Eyre et al., 1984). 
2. Adhesive Glycoprotein 
Adhesive glycoproteins are molecules that bind to the cells via a cell surface receptor 
called integrin and also other extracellular matrix components (Lorenz and Longaker, 
2008, Enoch and Leaper, 2007). Glycoprotein has two binding sites, one for collagen 
and another for cell surfaces and it influences attachment, spreading and migration of 
cells (Enoch and Leaper, 2007, Irvin, 1985). These molecules include fibronectin, 
laminin and vitronectin and are known as attachment factors (Davidson, 2002). 
3. Glycosaminoglycans and Proteoglycans 
Glycosaminoglycans are polysaccharide chains which include hyaluroran or 
hyaluronic acid, dermatan sulphate, chondroitin sulphate, heparin sulphate, and 
keratin sulphate. Hyaluroran promotes cell migration in early granulation tissue 
(Toole, 1991). 
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Proteoglycan contains a core protein, one of which is glycosaminoglycan chain (e.g. 
chondroitin -4 sulphate and dermatan sulphate) and is bound covalently (Clark, 
1996). Proteoglycans can alter the cell growth and cell differentiation (Enoch and 
Leaper, 2007). Proteoglycan that contained chondroitin-4-sulphate and dermatan 
sulphate increase in the second week of healing process (Bentley, 1967), and this 
proteoglycan is produced by mature fibroblast (Bronson et al., 1988). 
4. Matricellular proteins 
Matricelluar proteins are a group of proteins including galectins, osteopontin, 
secreted protein acidic and rich in cysteine (SPARC), tenascins, thrombospondins, 
and vitronectin (Midwood et al., 2004, Davidson, 2002). Most of these proteins 
interact via integrin and response to certain growth factors which also affect the cell 
migration, contraction of matrix and angiogenesis (Midwood et al., 2004). 
c. Granulation Tissue Formation 
Granulation tissue is formed on day 3 – 5 (around day 4) after injury. Granulation 
tissue consists of macrophages, proliferating fibroblast and new capillaries in a loose 
ECM (Enoch and Leaper, 2007, Cockbill, 2002, Singer and Clark, 1999). 
Granulation tissue has a pink or rossy, soft, granular gross appearance (Myers, 2008, 
Enoch and Leaper, 2007) which is created by the formation of new blood vessel and 
extracellular matrix. 
The new formation of blood vessel from pre-existing vessels is called angiogenesis 
(Bicknell and Harris, 2004, Augustin, 2001) or neovascularisation (Enoch and 
Leaper, 2007). Angiogenesis is stimulated by the vascular endothelial growth factor 
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(VEGF) and basic fibroblast growth factor (bFGF) (Bicknell and Harris, 2004), 
which are mainly produced by macrophages (Kondo and Ishida, 2010). It is 
important to maintain the newly formed granulation tissue because it provides 
oxygen and nutrition for the fibroblast to proliferate and to produce collagen 
(Tonnesen et al., 2000, Singer and Clark, 1999).           
d. Epithelialisation 
A single layer of epidermal cells migration occurs in the few hours after injury from 
the edge of the wound (uninjured area) covering the bare area which known as 
epiboly process (Lorenz and Longaker, 2008, Enoch and Leaper, 2007). 
Approximately 12 hours after the initiation of migration, there is a sign of increase in 
mitotic activity within epithelial cells of the wound edge. Epithelialisation process is 
altered by several growth factors like keratinocyte growth factor, epidermal growth 
factor and basic fibroblast growth factor (Enoch and Leaper, 2007; Monaco and 
Lawrence, 2003). Epithelial cells will continue to proliferate, migrate and 
differentiate to make a protective outer layer or stratum corneum which allows the 
restoration of surface integrity (Enoch and Leaper, 2007, Grazul-Bliska, et al., 2003, 
Keast and Orsted, 1998).  
 
1.5.4. Maturation or Remodelling phase 
This stage marks the end of the healing process since all of the aspects included in 
the healing process is back to near its pre-wounding level (Braiman-Wiksman et al., 
2007). In this stage, wound contraction occurs to close the gap of the wound. The 
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contraction of wound had been investigated by Gabbiani et al. (1971) and they found 
that the contraction was initiated by the modified fibroblast which is known as the 
myofibroblast. 
Wound remodelling starts approximately 21 days after injury (Enoch and Leaper, 
2007; Monaco and Lawrence, 2003). Collagen synthesis begins to deprive which 
regulated by γ-interferon, tumor necrosis factor (TNF-α) and collagen matrix itself 
(Monaco and Lawrence, 2003). The matured collagens change its structure during 
the alteration from granulation tissue to scar to perform more stable state (Singer and 
Clark, 1999). This collagen remodelling is also affected by collagenolysis process 
which is also important in the removal of collagen debris in injured tissue (Halloran 
and Slavin, 2002). Collagenolysis happened in a lower rate with the help of an 
enzyme called collagenase which is a member of matrix metalloproteinases (MMPs) 
family. MMPs family is produced by fibroblast, endothelial cells, neutrophils and 
macrophages (Diegelmann and Evans, 2004; Williamson and Harding, 2004; 
Halloran and Slavin, 2002; Singer and Clark, 1999). Other enzymes of MMPs 
members are gelatinases and stromelysins which are also involved in matrix 
degradation (Grazul-Bliska, et al., 2003). 
Although this is the last phase, it can last from 3 weeks up to two years (Lorenz and 
Longaker, 2008, Eccleston, 2007, Cockbill, 2002, Keast and Orsted, 1998) or even 
several years (Guo and DiPietro, 2009, Lawrence and Diegelmann, 1994). At this 
phase, wounded skin gets back its strength and elasticity (Braiman-Wiksman et al., 
2007). However, the strength of the scar tissue will only regain 70% to 80% of the 
original (unwounded) skin (Enoch and Leaper, 2007, Diegelmann and Evans, 2004, 
Williamson and Harding, 2004, Cockbill, 2002, Levenson et al., 1965). 
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1.6. GROWTH FACTORS AND CYTOKINES  
The cells that are involved in the wound healing process include fibroblasts, 
epithelial cells and vascular endothelial cells which secrete various growth factors 
and cytokines (Walsh, 1998). Growth factor is made up of amino acids which then 
form polypeptide (Martin et al., 1992). There are several growth factors and 
cytokines that play a significant role in the wound healing process. The contribution 
of these growth factors and cytokines in wound healing can be seen in Table 1.2 and 
Table 1.3. 
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Table 1.2: Growth Factors in Wound Healing 
Growth Factors Sources Functions References 
Transforming 
Growth Factors 
(TGF) β1 and β2 
  
  
  
  
  
  
  
Macrophages, 
platelets, fibroblasts, 
keratinocytes, bone 
cells 
  
  
  
  
  
  
  
Chemoattractant to fibroblast, monocytes, 
lymphocytes 
Lorenz and Longaker (2008),  Diegelmann 
and Evans (2004), Kumar et al. (2004), 
Grazul-Bliska, et al. (2003), Monaco and 
Lawrence (2003), Singer and Clark (1999), 
Walsh (1998), Lawrence and Diegelmann 
(1994) 
Proliferation of epithelial cells, 
macrophages, lymphocytes, fibroblast 
Lorenz and Longaker (2008), Diegelmann and 
Evans (2004), Kumar et al. (2004), Grazul-
Bliska, et al. (2003), Lawrence and 
Diegelmann (1994) 
Stimulates keratinocytes migration Kumar et al. (2004), Singer and Clark (1999) 
Induce synthesis of extracellular matrix 
proteins 
Lorenz and Longaker (2008), Diegelmann and 
Evans (2004), Singer and Clark (1999), Walsh 
(1998) 
Induce fibroblast to secrete tissue inhibitor 
of metallo-protease (TIMP) 
Diegelmann and Evans (2004), Kumar et al. 
(2004) 
Stimulate fibroblast to contract collagen 
matrix 
Kumar  et al. (2004), Grazul-Bliska et al. 
(2003),  
Modulate collagen and collagenase 
expression 
Diegelmann and Evans (2004) 
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TGF β3 Macrophages Antiscarring Lorenz and Longaker (2008), Tyrone et al. 
(2000), Singer and Clark (1999) 
TGF α Macrophages, 
Platelets, 
keratinocytes,  
Fibroblast 
Stimulates proliferation of fibroblast and 
epithelial cells 
Kondo and Ishida (2010), Lorenz and 
Longaker (2008), Lawrence and Diegelmann 
(1994), Martin et al. (1992) 
Angiogenic factor Bennett and Schultz (1993), Martin et al. 
(1992) 
Platelet derived 
growth factor 
(PDGF) 
  
  
  
  
  
  
  
  
  
Plaletes, fibroblasts, 
macrophages, 
endothelial cells, 
vascular smooth 
muscle cells, 
epidermal cells 
  
  
  
  
  
  
  
  
  
Chemoattractant for fibroblast, 
neutrophils, monocytes, smooth muscle 
cells, lymphocytes 
Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Kumar et al. (2004), 
Diegelmann and Evans (2004), Grazul-Bliska 
et al. (2003),  Monaco and Lawrence (2003), 
Halloran and Slavin (2002), Singer and Clark 
(1999), Walsh (1998), Lawrence and 
Diegelmann (1994), Martin et al. (1992), 
Lynch et al. (1989) 
Stimulate mitogenic for fibroblast and 
smooth muscle cells 
Enoch and Leaper (2007), Diegelmann and 
Evans (2004), Grazul-Bliska (2003), Walsh 
(1998), Bennett and Schultz (1993), Lynch et 
al. (1989) 
Monocyte maturation Kumar et al. (2004) 
Potentiates VEGF production Kumar et al. (2004) 
Stimulate MMP production by fibroblast Kumar et al. (2004), Lynch et al. (1989) 
Stimulates myofibroblast to contract 
matrix collagen 
Lorenz and Longaker (2008), Kumar et al. 
(2004) 
Induce fibroblast proliferation Enoch and Leaper (2007), Lorenz and 
Longaker (2008), Singer and Clark (1999), 
Witte and Barbul (1997), Lawrence and 
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Diegelmann (1994) 
Stimulates collagen synthesis Enoch and Leaper (2007), Monaco and 
Lawrence (2003), Martin et al. (1992) 
Increase TGF-β and MCP-1 synthesis Halloran and Slavin (2002) 
Increase integrin expression Halloran and Slavin (2002) 
Epidermal Growth 
Factor (EGF) 
  
  
 
Platelets, 
macrophages, 
keratinocytes 
  
  
  
Increase epithelialisation and promotes 
migration of keratinocytes 
Grazul-Bliska et al. (2003), Lawrence and 
Diegelmann (1994), Bennett and Schultz 
(1993) 
Increase granulation tissue Lawrence and Diegelmann (1994), Lynch et 
al. (1989) 
Increase fibroblast proliferation Witte and Barbul (1997), Lawrence and 
Diegelmann (1994), Bennett and Schultz 
(1993), Martin et al. (1992) 
Stimulates angiogenesis Lawrence and Diegelmann (1994), Martin et 
al. (1992) 
Stimulates collagenase activity Lawrence and Diegelmann (1994) 
Chemoattractant for fibroblast, endothelial 
cells 
Lorenz and Longaker (2008), Lawrence and 
Diegelmann (1994), Martin et al. (1992) 
basic Fibroblast 
Growth factor 
(bFGF) 
  
  
  
  
Macrophages, 
fibroblast, endothelial 
cells, keratinocytes, 
vascular smooth 
muscle cells, brain, 
pituitary and mast 
cells 
  
Angiogenic factor Kondo and Ishida (2010), Lorenz and 
Longaker (2008), Enoch and Leaper (2007), 
Oberyszyn (2007), Grazul-Bliska et al. 
(2003), Monaco and Lawrence (2003), 
Cockbill (2002), Halloran and Slavin (2002), 
Prathiba and Gupta (2000), Tonnesen et al. 
(2000), Ortega et al. (1998), Singer and Clark 
(1999), Lawrence and Diegelmann (1994), 
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Martin et al. (1992), Lynch, et al. (1989), 
Montesano et al. (1986) 
Increase proliferation of cappilary 
endothelial cells, keratinocytes, epithelial 
cells, fibroblasts 
Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Grazul-Bliska et al. (2003), 
Cockbill (2002), Singer and Clark (1999),  
,Lawrence and Diegelmann (1994), Tsuboi 
and Rifkin (1990) 
Chemoattractant for endothelial cells, 
fibroblasts, and keratinocytes 
Lorenz and Longaker (2008), Grazul-Bliska 
(2003), Halloran and Slavin (2002), Ortega 
(1998), Tsuboi and Rifkin (1990)  
Stimulates collagen, fibronectin, and 
proteoglycan synthesis 
Enoch and Leaper (2007),  Oberyszyn (2007), 
Grazul-Bliska et al. (2003), Lynch, et al. 
(1989) 
Neurotrophic factor Grazul-Bliska et al. (2003), Ortega (1998), 
Bennett and Schultz (1993) 
Keratinocytes 
growth Factor 
(KGF) 
  
Fibroblasts 
  
Stimulates keratinocytes and fibroblasts 
motility 
Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Kumar et al. (2004), Grazul-
Bliska et al. (2003), Singer and Clark (1999) 
Increase proliferation of keratinocytes Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Werner et al. (2007), Grazul-
Bliska et al. (2003), Cockbill (2002), Singer 
and Clark (1999), Lawrence and Diegelmann 
(1994), Bennet and Schultz (1993), Martin et 
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al. (1992) 
Vascular 
Endothelial 
Growth factor 
(VEGF) 
  
  
  
  
Platelets, 
macrophages, 
fibroblasts, 
keartinocytes, smooth 
muscle cells, 
neutrophils, mast cells 
  
  
  
  
Angiogenic factor Kondo and Ishida (2010), Bao et al. (2009), 
Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Oberyszyn (2007), 
Diegelmann and Evans (2004), Kumar et al. 
(2004), Grazul-Bliska et al. (2003), Halloran 
and Slavin (2002), Tonnesen et al. (2000), 
Singer and Clark (1999) 
Chemoattractant Halloran and Slavin (2002),  Bao et al. (2009) 
Induces procoagulant factors in 
endothelial cells 
Bao et al. (2009) 
Induces endothelial cells migration Bao et al. (2009) 
Increase proliferation of endothelial cells Bao et al. (2009), Bennett and Schultz (1993) 
Insulin -like 
Growth Factor 
(IGF) 
  
  
  
Liver, fibroblasts, 
epidermal cells 
  
  
  
Stimulates cellular growth and 
differentiation 
Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Grazul-Bliska et al. (2003), 
Walsh (1998), Singer and Clark (1999), Witte 
and Barbul (1997),  
Stimulates collagen synthesis by fibroblast Lorenz and Longaker (2008), Enoch and 
Leaper (2007), Lawrence and Diegelmann 
(1994) 
Increase re-epithelialisation and 
granulation tissue formation 
Singer and Clark (1999) 
Stimulates  synthesis of sulphates 
proteoglycans 
Enoch and Leaper (2007), Lawrence and 
Diegelmann (1994) 
